Brought to you by 
Lonza acquires oral delivery capsule CDMO Capsugel for $5.5bn
29 Sep 2020
Executive Summary
Lonza Group Ltd. has agreed to acquire fellow contract development and manufacturing organization (CDMO) Capsugel SA (oral dosage delivery technologies and capsule design) from private equity firm Kohlberg Kravis Roberts & Co. LP (KKR).
Deal Industry
- Pharmaceuticals
- Services
-
Pharmaceuticals
- Drug Delivery
-
Biotechnology
- Synthesis Technologies, Production Processes
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Intra-Biotech Deal
- Payment Includes Cash for Equity
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Lonza acquires oral delivery capsule CDMO Capsugel for $5.5bn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice